Our sleep center can be used to support drug development across Phase I-IV and provide you with a unique tool for evaluations of novel compounds as well as currently prescribed medications. Presence of sleep disordered breathing and changes in sleep architecture can be quantified, to assess the impact of drugs on CNS physiological processes. Additionally, monitoring of atypical physiological parameters can easily be added to our sleep montage to support your specific research requirements.
Our primary sleep center has a total of 10 beds dedicated to research. Our Laboratory Director is a past director of the National Registry of Polysomnography Technicians (RPSGT) and our Medical Co-Director is a Diplomat of the American Academy of Sleep Medicine and is Board Certified in Pulmonary Medicine. Our Medical Senior Sleep Staff has more than 50 years of experience.
The sleep environments meet AASM accreditation standards and are staffed with Registered Polysomnographic (PSG) Technicians who lead, score and monitor the quality of data acquisition. All of our beds are video monitored, and feature MedCare Diagnostics, Rembrandt Sleep Systems for data capture, scoring & report generation.
Our interests are focused on the evaluation of multiple sleep-related indications:
- Impact of Pain
- CNS Medications
- Multiple Sleep Latency
- Transient Insomnia
- Chronic Insomnia
- Sleep Apnea
- Shift Work Disorder
- Restless Leg Syndrome
- Evaluation of non-sleep medications on sleep architecture & sleep disordered breathing.
The work that CRI Lifetree are currently doing will be some of the first studies that will lead to guidelines or recommendations regarding the need for sleep testing in patients receiving CNS medications. Our research in this area will be the first to raise serious concerns and could have an enormous impact regarding the way in which patients are evaluated and monitored nationally and internationally.